Antibody-drug Conjugates Market Report

Global and Europe Antibody-drug Conjugates Market Professional Survey Report 2019

  • POSTDATE：Jun 11, 2020
  • PAGES：214
  • REPORT CODE：GMM543046
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Antibody-drug Conjugates market was valued at XX.0 million US$ in 2018, with the CAGR of 1.9%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Antibody-drug Conjugates market. Describe product range of Antibody-drug Conjugates, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Antibody-drug Conjugates market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Antibody-drug Conjugates market.

     

    By Player

    • ImmunoGen

    • Seattle Genetics

    • Takeda

    • Roche

    By Type

    • Adcetris

    • Kadcyla

    By End-User

    • Breast Cancer

    • Lymphoma

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibody-drug Conjugates Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Antibody-drug Conjugates Market Size and Growth Rate of Adcetris from 2014 to 2026

      • 1.3.2 Global Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.2 Global Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Antibody-drug Conjugates Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Antibody-drug Conjugates Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antibody-drug Conjugates by Major Types

      • 3.4.1 Antibody-drug Conjugates Market Size and Growth Rate of Adcetris

      • 3.4.2 Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla

    4 Segmentation of Antibody-drug Conjugates Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antibody-drug Conjugates by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antibody-drug Conjugates for Breast Cancer

      • 4.4.2 Market Size and Growth Rate of Antibody-drug Conjugates for Lymphoma

    5 Market Analysis by Major Regions

    • 5.1 Global Antibody-drug Conjugates Production Analysis by Top Regions

    • 5.2 Global Antibody-drug Conjugates Consumption Analysis by Top Regions

    • 5.3 Global Antibody-drug Conjugates Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

    6 Product Circulation of Antibody-drug Conjugates Market among Top Countries

    • 6.1 Top 5 Export Countries in Antibody-drug Conjugates Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Antibody-drug Conjugates Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Antibody-drug Conjugates Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Antibody-drug Conjugates Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Antibody-drug Conjugates Landscape Analysis

    • 7.1 North America Antibody-drug Conjugates Landscape Analysis by Top Countries

      • 7.1.1 United States Antibody-drug Conjugates Market Volume and Growth Rate

      • 7.1.2 Canada Antibody-drug Conjugates Market Volume and Growth Rate

      • 7.1.3 Mexico Antibody-drug Conjugates Market Volume and Growth Rate

    8. Europe Antibody-drug Conjugates Landscape Analysis

    • 8.1 Europe Antibody-drug Conjugates Landscape Analysis by Major Types

    • 8.2 Europe Antibody-drug Conjugates Landscape Analysis by Major End-Users

    • 8.3 Europe Antibody-drug Conjugates Landscape Analysis by Top Countries

      • 8.3.1 Germany Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.2 UK Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.3 France Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.4 Italy Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.5 Spain Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.6 Belgium Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.7 Poland Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.8 Russia Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.9 Turkey Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.10 Netherlands Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.11 Portugal Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.12 Denmark Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.13 Finland Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.14 Iceland Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.15 Norway Antibody-drug Conjugates Market Volume and Growth Rate

      • 8.3.16 Sweden Antibody-drug Conjugates Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Antibody-drug Conjugates Landscape Analysis

    • 9.1 Asia Pacific Antibody-drug Conjugates Landscape Analysis by Top Countries

      • 9.1.1 China Antibody-drug Conjugates Market Volume and Growth Rate

      • 9.1.2 Japan Antibody-drug Conjugates Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Antibody-drug Conjugates Market Volume and Growth Rate

      • 9.1.4 India Antibody-drug Conjugates Market Volume and Growth Rate

      • 9.1.5 ASEAN Antibody-drug Conjugates Market Volume and Growth Rate

      • 9.1.6 South Korea Antibody-drug Conjugates Market Volume and Growth Rate

    10 LAMEA Antibody-drug Conjugates Landscape Analysis

    • 10.1 LAMEA Antibody-drug Conjugates Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Antibody-drug Conjugates Market Volume and Growth Rate

      • 10.1.2 Brazil Antibody-drug Conjugates Market Volume and Growth Rate

      • 10.1.3 North Africa Antibody-drug Conjugates Market Volume and Growth Rate

      • 10.1.4 South Africa Antibody-drug Conjugates Market Volume and Growth Rate

      • 10.1.5 Argentina Antibody-drug Conjugates Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 ImmunoGen

      • 11.1.1 ImmunoGen Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Seattle Genetics

      • 11.2.1 Seattle Genetics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Takeda

      • 11.3.1 Takeda Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Roche

      • 11.4.1 Roche Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 94 Figures and 173 Tables)

    • Figure Product Picture

    • Figure Antibody-drug Conjugates Market Size and Growth Rate of Adcetris from 2014 to 2026

    • Figure Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla from 2014 to 2026

    • Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure North America Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure United States Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure UK Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure France Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure China Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure India Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Antibody-drug Conjugates Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Antibody-drug Conjugates Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Antibody-drug Conjugates

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antibody-drug Conjugates by Different Types from 2014 to 2026

    • Table Consumption Share of Antibody-drug Conjugates by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Adcetris

    • Figure Market Size and Growth Rate of Kadcyla

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Antibody-drug Conjugates by Different End-Users from 2014 to 2026

    • Table Consumption Share of Antibody-drug Conjugates by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Lymphoma

    • Table Global Antibody-drug Conjugates Production by Major Regions

    • Table Global Antibody-drug Conjugates Production Share by Major Regions

    • Table Global Antibody-drug Conjugates Consumption by Major Regions

    • Table Global Antibody-drug Conjugates Consumption Share by Major Regions

    • Table North America Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

    • Table Europe Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

    • Table LAMEA Antibody-drug Conjugates Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Antibody-drug Conjugates Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Antibody-drug Conjugates Consumption by Major Countries from 2014 to 2026

    • Table North America Antibody-drug Conjugates Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Antibody-drug Conjugates Consumption Share by Major Countries in 2014

    • Figure North America Antibody-drug Conjugates Consumption Share by Major Countries in 2018

    • Figure North America Antibody-drug Conjugates Consumption Share by Major Countries in 2026

    • Figure United States Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption by Types from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption Share by Types from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption by End-Users from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption Share by End-Users from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption by Major Countries from 2014 to 2026

    • Table Europe Antibody-drug Conjugates Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure France Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Antibody-drug Conjugates Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Antibody-drug Conjugates Consumption Share by Major Countries from 2014 to 2026

    • Figure China Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure India Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Antibody-drug Conjugates Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Antibody-drug Conjugates Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Antibody-drug Conjugates Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of ImmunoGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunoGen

    • Figure Sales and Growth Rate Analysis of ImmunoGen

    • Figure Revenue and Market Share Analysis of ImmunoGen

    • Table Product and Service Introduction of ImmunoGen

    • Table Company Profile and Development Status of Seattle Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics

    • Figure Sales and Growth Rate Analysis of Seattle Genetics

    • Figure Revenue and Market Share Analysis of Seattle Genetics

    • Table Product and Service Introduction of Seattle Genetics

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US